What is the significance of the ENT endoscopic findings showing moderate medial arytenoid effacement, laryngeal erythema, and mild interarytenoid thickening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ENT Scope Findings Interpretation

Your endoscopy shows signs consistent with chronic laryngitis, most likely related to laryngopharyngeal reflux (LPR), characterized by moderate medial arytenoid effacement, laryngeal erythema, and mild interarytenoid (IA) thickening—findings that suggest chronic inflammation of the larynx.

What These Findings Mean

The key abnormal findings in your report are:

  • Moderate effacement of the medial arytenoid: Flattening or loss of normal contour of the arytenoid cartilage structures
  • Laryngeal erythema: Redness/inflammation of the laryngeal tissues
  • Mild interarytenoid (IA) thickening: Swelling or tissue buildup in the space between the arytenoid cartilages
  • Mucoid post-nasal drainage with waterfall effect: Mucus draining from the nasopharynx

The remainder of your examination is reassuringly normal—no masses, obstructions, pooling of secretions, or concerning lesions anywhere in the nose, nasopharynx, oropharynx, or hypopharynx.

Clinical Significance

These Findings Suggest Chronic Laryngitis

The combination of medial arytenoid changes, erythema, and interarytenoid thickening are classic laryngoscopic signs of chronic laryngitis 1. The interarytenoid mucosa abnormalities are particularly significant—mucosal lesions of the interarytenoid notch increase the odds of reflux-related laryngitis by 21-fold 2, 3.

Important Caveats About These Findings

However, there are critical limitations to interpreting these findings:

  • Poor specificity: These same findings (erythema of the medial arytenoid, posterior commissure changes, and interarytenoid abnormalities) have been documented in healthy volunteers without reflux symptoms 1
  • Poor reliability: Studies show moderate to poor inter-rater reliability for identifying edema and erythema of the vocal folds and arytenoids, with results varying based on whether rigid or flexible laryngoscopy was used 1
  • One large study of 1,209 patients found no difference in interarytenoid bar findings, arytenoid erythema, or posterior commissure changes between GERD patients and controls 4

What's Reassuring

No worrisome features are present: There are no masses, ulcerations, significant vocal fold abnormalities (no pseudosulcus vocalis or posterior commissure thickening), or pooling of secretions that would suggest malignancy, vocal fold paralysis, or other serious pathology 5.

Clinical Approach

If You Have Voice Symptoms (Hoarseness, Throat Clearing, Chronic Cough)

Anti-reflux medication may be considered as a treatment option 1. The AAO-HNS guidelines state that clinicians may prescribe anti-reflux medication for patients with hoarseness AND signs of chronic laryngitis (which you have) 1.

The evidence shows:

  • Abnormalities of the interarytenoid mucosa and true vocal folds were predictive of improvement in laryngeal symptoms with PPI treatment 1
  • However, randomized trials show mixed results—some studies found no benefit in symptom scores despite laryngoscopic improvement 1

If You Have NO Voice or Reflux Symptoms

Do not start anti-reflux medications empirically 1. The guidelines explicitly recommend against prescribing anti-reflux medications for patients without signs or symptoms of GERD, given known adverse effects (increased fracture risk, vitamin B12 deficiency, iron deficiency anemia, pancreatitis risk) and limited evidence of benefit 1.

What NOT to Do

Avoid oral corticosteroids—the AAO-HNS guidelines recommend against routinely prescribing oral corticosteroids for hoarseness, based on absence of clinical benefit and documented adverse events 1.

Bottom Line

Your findings represent mild-to-moderate chronic laryngeal inflammation. While suggestive of reflux-related changes, these findings alone are not diagnostic and can be seen in normal individuals. The clinical decision to treat should be based on your symptoms (hoarseness, throat clearing, chronic cough, globus sensation) rather than the laryngoscopic findings alone. Most importantly, there are no concerning features suggesting malignancy or other serious pathology requiring urgent intervention.

References

Guideline

clinical practice guideline: hoarseness (dysphonia).

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2009

Guideline

clinical practice guideline: hoarseness (dysphonia) (update).

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2018

Related Questions

In a healthy 5-year-old who fell three feet from monkey bars, landing on his buttocks, and now has persistent thoracic back pain, what injuries must be ruled out?
In an 85-year-old patient with sweating and feeling hot (hot flashes), what are the likely causes and how should it be evaluated?
What is the appropriate management for a 10‑month‑old infant with cough, wheezing, coarse breath sounds, and diarrhea?
Is a morning blood pressure of 105/54 mm Hg normal, and what management is recommended if the patient is asymptomatic?
What does an R‑S‑R (RSR') pattern in ECG leads II, III, and aVF indicate?
What are the recommended ergocalciferol (vitamin D₂) dosing regimens for correcting deficiency in adults, including loading and maintenance doses, and how should dosing be adjusted for severe deficiency, chronic kidney disease, and pediatric patients?
What are the Canadian guidelines for evaluating and managing an elevated prostate-specific antigen (PSA) in adult males?
What is the significance of a lactate dehydrogenase (LDH) level of 261 U/L?
What patterns are observed on the video head‑impulse test (vHIT) in a patient with a posterior inferior cerebellar artery (PICA) infarct?
Is pregabalin contraindicated in patients with liver cirrhosis, and how should dosing be adjusted for mild, moderate, and severe hepatic impairment?
For a 38‑year‑old woman with a prior miscarriage and normal results on non‑invasive prenatal testing (NIPT), first‑trimester ultrasound with nuchal translucency, and combined serum hCG and PAPP‑A screening, does the combined screening provide high sensitivity for Down syndrome such that invasive testing (e.g., chorionic villus sampling) is unnecessary?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.